Rain Oncology

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	37.31 mm	37.31 mm	37.31 mm	37.31 mm	37.31 mm	37.31 mm
Cash burn (monthly)	921.33 k	210.17 k	2.69 mm	6.38 mm	2.33 mm	5.48 mm
Cash used (since last report)	14.85 mm	3.39 mm	43.39 mm	102.87 mm	37.59 mm	88.30 mm
Cash remaining	22.47 mm	33.93 mm	-6.08 mm	-65.56 mm	-281.75 k	-50.99 mm
Runway (months of cash)	24.4	161.4	-2.3	-10.3	-0.1	-9.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2023

Rain Oncology institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	61	67	-9.0%
Opened positions	9	31	-71.0%
Closed positions	15	27	-44.4%
Increased positions	13	20	-35.0%
Reduced positions	18	7	+157.1%

13F shares	Current	Prev Q	Change
Total value	13.36 bn	17.58 bn	-24.0%
Total shares	28.42 mm	28.94 mm	-1.8%
Total puts	500.00	30.80 k	-98.4%
Total calls	19.80 k	37.00 k	-46.5%
Total put/call ratio	0.0	0.8	-97.0%

Largest owners	Shares	Value	Change
Tang Capital Partners	3.74 mm	$4.64 mm	0.0%
Tang Capital Management	3.74 mm	$3.22 bn	0.0%
Biotechnology Value Fund L P	3.53 mm	$4.16 mm	0.0%
BVF	3.53 mm	$3.04 bn	0.0%
Cormorant Global Healthcare Master Fund	2.73 mm	$0.00	0.0%
Samsara BioCapital	2.26 mm	$35.72 mm	0.0%
Samsara BioCapital	2.03 mm	$1.75 bn	0.0%
Boxer Capital	1.15 mm	$992.98 mm	0.0%
BLK BlackRock	1.02 mm	$875.06 mm	-0.1%
Vanguard	902.66 k	$777.92 mm	-0.3%

Largest transactions	Shares	Bought/sold	Change
Millennium Management	0.00	-601.14 k	EXIT
Acuitas Investments	409.26 k	+409.26 k	NEW
Russell Investments	395.94 k	+395.94 k	NEW
Western Standard	0.00	-347.09 k	EXIT
GS The Goldman Sachs Group, Inc.	28.43 k	-210.18 k	-88.1%
Two Sigma Advisers	216.90 k	+95.40 k	+78.5%
Jane Street	0.00	-91.16 k	EXIT
Marquette Asset Management	84.14 k	+84.14 k	NEW
New York State Common Retirement Fund	1.38 k	-76.82 k	-98.2%
Gsa Capital Partners	0.00	-61.30 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

Rain Oncology insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value
26 Jan 24	Avanish Vellanki	Common Stock, par value $0.001 per share		Dispose U	No	No	0	2,550,910	0.00
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	8.02	152,150	1.22 mm
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	1.21	133,250	161.23 k
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	1.21	266,500	322.46 k
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	9.3	304,485	2.83 mm
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	8.02	30,150	241.80 k
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	4	31,832	127.33 k
26 Jan 24	Avanish Vellanki	Stock Option Common Stock	Sale back to company	Dispose D	No	No	9.3	14,115	131.27 k
26 Jan 24	Robert Doebele	Common Stock, par value $0.001 per share		Dispose U	No	No	0	476,827	0.00
26 Jan 24	Robert Doebele	Stock Option Common Stock	Sale back to company	Dispose D	No	No	12.01	59,642	716.30 k

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.